Kun-Ju Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kun-Ju Zhu has a total of 283 co-authors. Here are the top co-authors by number of shared publications:
Chi Zhang
Anhui Provincial Hospital Affiliated to Anhui Medical University
9 shared publicationsSen Yang
Department of Dermatology, Institute of Dermatology No. 1 Hospital, Anhui Medical University, Hefei, Anhui, China
9 shared publicationsZheng Zhang
Department of Dermatology, Institute of Dermatology No. 1 Hospital, Anhui Medical University, Hefei, Anhui, China
9 shared publicationsHui Cheng
Department of Dermatology, Institute of Dermatology No. 1 Hospital, Anhui Medical University, Hefei, Anhui, China
8 shared publicationsYang Li
Department of Dermatology, Institute of Dermatology No. 1 Hospital, Anhui Medical University, Hefei, Anhui, China
8 shared publications- Xuejun Zhang
Institute of Dermatology and Department of Dermatology at No.1 Hospital, Anhui Medical University, Hefei, China
7 shared publications
Latest Publications
- Open Access
MicroRNA-146a polymorphisms are Associated with Psoriasis Vulgaris
MicroRNA-146a acts as a critical physiological brake role to prevent the overactivation of inflammatory response pathways and was a key negative regulator of autoimmunity. Ets-1 could bind to the MicroRNA-146a promoter region as a regulator of MicroRNA-146a expression in vitro. IRAK1 is a prominent target of MicroRNA-146a that help it to negatively regulate the release of IL8. This study aimed to investigate the association of MicroRNA-146a, Ets-1(negative regulator) and IRAK1(target) polymorphisms with Psoriasis Vulgaris( PsV ), the most prevalent chronic inflammatory skin disease in adults, in a Southern Chinese cohort. Seven SNPs in microRNA-146a (rs2431697; rs2910164; rs57095329), Ets-1(rs10893872; rs1128334) and IRAK1(rs1059703; rs3027898) genes were genotyped in 673 subjects (360 PsV cases and 313 controls) by SNaPshot Multiplex Kit (Applied Biosystems Co., USA). We found significant difference in the genotype and allele frequencies of rs2431697 and rs2910164 in MicroRNA-146a gene between the PsV cases and the controls. The dominant model genotype (CC+CT) ( p =0.019; OR=1.463) and allele (C) ( p =0.027; OR=1.496) of rs2431697 and the GG genotype ( p = 0.027; OR=1.582) and allele (G) of rs2910164 were associated with an increased risk of PsV. There was no association of the SNPs with the clinical traits of PsV. Our data provide preliminary evidence that the rs2431697 and rs2910164 polymorphism in the microRNA-146a gene may be involved in the genetic susceptibility to PsV in Southern Chinese. Although further function studies will be required to identify the details of the process, the findings could make a significant step forward in our understanding of the genetic contribution to psoriasis. What’s already known about this topic?: MicroRNA-146a is one of the most highly associated MicroRNA to psoriasis. MicroRNA-146a acts as a critical physiological brake role to prevent the overactivation of inflammatory response pathways and was a key negative regulator of autoimmunity. What does this study add?: Our data provide preliminary evidence that the rs2431697 and rs2910164 polymorphism in the microRNA-146a gene are involved in the genetic susceptibility to PsV in Southern Chinese.
Open AccessMicroRNA-146a polymorphisms are Associated with Psoriasis Vulgaris
MicroRNA-146a acts as a critical physiological brake role to prevent the overactivation of inflammatory response pathways and was a key negative regulator of autoimmunity. Ets-1 could bind to the MicroRNA-146a promoter region as a regulator of MicroRNA-146a expression in vitro. IRAK1 is a prominent target of MicroRNA-146a that help it to negatively regulate the release of IL8. This study aimed to investigate the association of MicroRNA-146a, Ets-1(negative regulator) and IRAK1(target) polymorphisms with Psoriasis Vulgaris( PsV ), the most prevalent chronic inflammatory skin disease in adults, in a Southern Chinese cohort. Seven SNPs in microRNA-146a (rs2431697; rs2910164; rs57095329), Ets-1(rs10893872; rs1128334) and IRAK1(rs1059703; rs3027898) genes were genotyped in 673 subjects (360 PsV cases and 313 controls) by SNaPshot Multiplex Kit (Applied Biosystems Co., USA). We found significant difference in the genotype and allele frequencies of rs2431697 and rs2910164 in MicroRNA-146a gene between the PsV cases and the controls. The dominant model genotype (CC+CT) ( p =0.019; OR=1.463) and allele (C) ( p =0.027; OR=1.496) of rs2431697 and the GG genotype ( p = 0.027; OR=1.582) and allele (G) of rs2910164 were associated with an increased risk of PsV. There was no association of the SNPs with the clinical traits of PsV. Our data provide preliminary evidence that the rs2431697 and rs2910164 polymorphism in the microRNA-146a gene may be involved in the genetic susceptibility to PsV in Southern Chinese. Although further function studies will be required to identify the details of the process, the findings could make a significant step forward in our understanding of the genetic contribution to psoriasis. What’s already known about this topic?: MicroRNA-146a is one of the most highly associated MicroRNA to psoriasis. MicroRNA-146a acts as a critical physiological brake role to prevent the overactivation of inflammatory response pathways and was a key negative regulator of autoimmunity. What does this study add?: Our data provide preliminary evidence that the rs2431697 and rs2910164 polymorphism in the microRNA-146a gene are involved in the genetic susceptibility to PsV in Southern Chinese.
- Open Access
- 21 September 2022
- Published by Springer Nature in Research Square
Using Psoriasis-Genes to readout Overlap Pathways from TCGA
One major challenge in studying the psoriasis is the lack of multi-omics and sufficient measurement datasets for psoriasis, which only provides limited insights into the pathogenesis of psoriasis. As the psoriasis is associated with the dysfunction of pathways, the pathogenesis of psoriasis can be investigated with the aids of big omics data from tumors in The Cancer Genome Atlas (TCGA), a data set that is in fact the records of random pathway perturbation experiments performed by nature. We first collect psoriasis related genes found by previous researches of psoriasis. We then utilize the gene expression and genomic alteration data from thousands of tumors in TCGA cohort to identify genomic alterations that potentially perturb pathways regulating expressions of these psoriasis related genes. We have found that genomic alterations of some genes are associated with the expression changes of psoriasis related genes in tumors, which implies that the genomic alteration of these genes may perturb pathways involved in the development of the psoriasis. For example, we found that SGAs of certain genes (E.g., TNFAIP8L3, IL-23, ANGPT2, IFIH1) are highly likely to be involved in the pathogenesis of psoriasis. Enrichment analysis showed that SGAs of these genes perturb signaling pathways regulating cell proliferation and/or angiogenesis-relevant activities of cells, which are well-known to be biologically related to the development of both psoriasis and cancers. The approach of using big genomic data of tumors to search for pathways involved in the psoriasis development gains insights into the mechanism of psoriasis.
- 21 September 2022
- Published by Springer Nature in Research Square
Open AccessUsing Psoriasis-Genes to readout Overlap Pathways from TCGA
One major challenge in studying the psoriasis is the lack of multi-omics and sufficient measurement datasets for psoriasis, which only provides limited insights into the pathogenesis of psoriasis. As the psoriasis is associated with the dysfunction of pathways, the pathogenesis of psoriasis can be investigated with the aids of big omics data from tumors in The Cancer Genome Atlas (TCGA), a data set that is in fact the records of random pathway perturbation experiments performed by nature. We first collect psoriasis related genes found by previous researches of psoriasis. We then utilize the gene expression and genomic alteration data from thousands of tumors in TCGA cohort to identify genomic alterations that potentially perturb pathways regulating expressions of these psoriasis related genes. We have found that genomic alterations of some genes are associated with the expression changes of psoriasis related genes in tumors, which implies that the genomic alteration of these genes may perturb pathways involved in the development of the psoriasis. For example, we found that SGAs of certain genes (E.g., TNFAIP8L3, IL-23, ANGPT2, IFIH1) are highly likely to be involved in the pathogenesis of psoriasis. Enrichment analysis showed that SGAs of these genes perturb signaling pathways regulating cell proliferation and/or angiogenesis-relevant activities of cells, which are well-known to be biologically related to the development of both psoriasis and cancers. The approach of using big genomic data of tumors to search for pathways involved in the psoriasis development gains insights into the mechanism of psoriasis.
- Open Access
- 5 April 2021
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 17 (4) , e1008792
ORN: Inferring patient-specific dysregulation status of pathway modules in cancer with OR-gate Network
Pathway level understanding of cancer plays a key role in precision oncology. However, the current amount of high-throughput data cannot support the elucidation of full pathway topology. In this study, instead of directly learning the pathway network, we adapted the probabilistic OR gate to model the modular structure of pathways and regulon. The resulting model, OR-gate Network (ORN), can simultaneously infer pathway modules of somatic alterations, patient-specific pathway dysregulation status, and downstream regulon. In a trained ORN, the differentially expressed genes (DEGs) in each tumour can be explained by somatic mutations perturbing a pathway module. Furthermore, the ORN handles one of the most important properties of pathway perturbation in tumours, the mutual exclusivity. We have applied the ORN to lower-grade glioma (LGG) samples and liver hepatocellular carcinoma (LIHC) samples in TCGA and breast cancer samples from METABRIC. Both datasets have shown abnormal pathway activities related to immune response and cell cycles. In LGG samples, ORN identified pathway modules closely related to glioma development and revealed two pathways closely related to patient survival. We had similar results with LIHC samples. Additional results from the METABRIC datasets showed that ORN could characterize critical mechanisms of cancer and connect them to less studied somatic mutations (e.g., BAP1, MIR604, MICAL3, and telomere activities), which may generate novel hypothesis for targeted therapy.
- 5 April 2021
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 17 (4) , e1008792
Open AccessORN: Inferring patient-specific dysregulation status of pathway modules in cancer with OR-gate Network
Pathway level understanding of cancer plays a key role in precision oncology. However, the current amount of high-throughput data cannot support the elucidation of full pathway topology. In this study, instead of directly learning the pathway network, we adapted the probabilistic OR gate to model the modular structure of pathways and regulon. The resulting model, OR-gate Network (ORN), can simultaneously infer pathway modules of somatic alterations, patient-specific pathway dysregulation status, and downstream regulon. In a trained ORN, the differentially expressed genes (DEGs) in each tumour can be explained by somatic mutations perturbing a pathway module. Furthermore, the ORN handles one of the most important properties of pathway perturbation in tumours, the mutual exclusivity. We have applied the ORN to lower-grade glioma (LGG) samples and liver hepatocellular carcinoma (LIHC) samples in TCGA and breast cancer samples from METABRIC. Both datasets have shown abnormal pathway activities related to immune response and cell cycles. In LGG samples, ORN identified pathway modules closely related to glioma development and revealed two pathways closely related to patient survival. We had similar results with LIHC samples. Additional results from the METABRIC datasets showed that ORN could characterize critical mechanisms of cancer and connect them to less studied somatic mutations (e.g., BAP1, MIR604, MICAL3, and telomere activities), which may generate novel hypothesis for targeted therapy.
- Open Access
- 1 September 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 95 (5) , 623-626
Tratamento bem‐sucedido de paciente com coinfecção cutânea causada por Mucor irregularis e Klebsiella pneumoniae
- 1 September 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 95 (5) , 623-626
Open AccessTratamento bem‐sucedido de paciente com coinfecção cutânea causada por Mucor irregularis e Klebsiella pneumoniae
- Open Access
- 1 September 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 95 (5) , 623-626
Successful treatment of a patient with cutaneous co-infection caused by Mucor irregularis and Klebsiella pneumoniae
- 1 September 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 95 (5) , 623-626
Open AccessSuccessful treatment of a patient with cutaneous co-infection caused by Mucor irregularis and Klebsiella pneumoniae
- Open Access
- 1 July 2020
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 36 (13) , 4030-4037
BEM: Mining Coregulation Patterns in Transcriptomics via Boolean Matrix Factorization
The matrix factorization is an important way to analyze coregulation patterns in transcriptomic data, which can reveal the tumor signal perturbation status and subtype classification. However, current matrix factorization methods do not provide clear bicluster structure. Furthermore, these algorithms are based on the assumption of linear combination, which may not be sufficient to capture the coregulation patterns. We presented a new algorithm for Boolean matrix factorization (BMF) via expectation maximization (BEM). BEM is more aligned with the molecular mechanism of transcriptomic coregulation and can scale to matrix with over 100 million data points. Synthetic experiments showed that BEM outperformed other BMF methods in terms of reconstruction error. Real-world application demonstrated that BEM is applicable to all kinds of transcriptomic data, including bulk RNA-seq, single-cell RNA-seq and spatial transcriptomic datasets. Given appropriate binarization, BEM was able to extract coregulation patterns consistent with disease subtypes, cell types or spatial anatomy. Python source code of BEM is available on https://github.com/LifanLiang/EM_BMF. Supplementary data are available at Bioinformatics online.
- 1 July 2020
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 36 (13) , 4030-4037
Open AccessBEM: Mining Coregulation Patterns in Transcriptomics via Boolean Matrix Factorization
The matrix factorization is an important way to analyze coregulation patterns in transcriptomic data, which can reveal the tumor signal perturbation status and subtype classification. However, current matrix factorization methods do not provide clear bicluster structure. Furthermore, these algorithms are based on the assumption of linear combination, which may not be sufficient to capture the coregulation patterns. We presented a new algorithm for Boolean matrix factorization (BMF) via expectation maximization (BEM). BEM is more aligned with the molecular mechanism of transcriptomic coregulation and can scale to matrix with over 100 million data points. Synthetic experiments showed that BEM outperformed other BMF methods in terms of reconstruction error. Real-world application demonstrated that BEM is applicable to all kinds of transcriptomic data, including bulk RNA-seq, single-cell RNA-seq and spatial transcriptomic datasets. Given appropriate binarization, BEM was able to extract coregulation patterns consistent with disease subtypes, cell types or spatial anatomy. Python source code of BEM is available on https://github.com/LifanLiang/EM_BMF. Supplementary data are available at Bioinformatics online.
- 12 August 2019
- Published by Springer Nature in Molecular Biology Reports
- Vol. 46 (6) , 5867-5874
The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis
In the last two decades, with the wide use of azoles, antifungal resistance among Candida parapsilosis has considered a matter of concern worldwide. The aim of this study is to evaluate the antifungal potentials of tetrandrine (TET) alone and in combination with fluconazole (FLC)/voriconazole (VRC) against C. parapsilosis. Susceptibility tests were performed by microdilution method, checkerboard assay, time-kill test, spot assay. Subsequently, rhodamine 6G efflux test and the expressions of transporter related genes, namely CDR1 and MDR1 for C. parapsilosis were analyzed by qRT-PCR. The susceptibility test showed that TET presented strong synergism with FLC and VRC with fractional inhibitory concentration index (FICI) in a range of 0.094–0.562. The susceptibility results were also confirmed by spot assay and time-kill studies. With TET treatment, a vast quantity of rhodamine 6G could not be pumped out from the cells as considerably intracellular red fluorescence was accumulated. Meanwhile, the expressions of efflux-associated genes presented varying degrees of inhibition. These results indicated that TET was a decent antifungal synergist to promote the antifungal efficacy of FLC/VRC, and the underlying antifungal mechanism might be associated with the inhibition of efflux pump and the elevation of intracellular drug content.
- 12 August 2019
- Published by Springer Nature in Molecular Biology Reports
- Vol. 46 (6) , 5867-5874
The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis
In the last two decades, with the wide use of azoles, antifungal resistance among Candida parapsilosis has considered a matter of concern worldwide. The aim of this study is to evaluate the antifungal potentials of tetrandrine (TET) alone and in combination with fluconazole (FLC)/voriconazole (VRC) against C. parapsilosis. Susceptibility tests were performed by microdilution method, checkerboard assay, time-kill test, spot assay. Subsequently, rhodamine 6G efflux test and the expressions of transporter related genes, namely CDR1 and MDR1 for C. parapsilosis were analyzed by qRT-PCR. The susceptibility test showed that TET presented strong synergism with FLC and VRC with fractional inhibitory concentration index (FICI) in a range of 0.094–0.562. The susceptibility results were also confirmed by spot assay and time-kill studies. With TET treatment, a vast quantity of rhodamine 6G could not be pumped out from the cells as considerably intracellular red fluorescence was accumulated. Meanwhile, the expressions of efflux-associated genes presented varying degrees of inhibition. These results indicated that TET was a decent antifungal synergist to promote the antifungal efficacy of FLC/VRC, and the underlying antifungal mechanism might be associated with the inhibition of efflux pump and the elevation of intracellular drug content.
- Open Access
- 2 May 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (1) , 225
Integrating data and knowledge to identify functional modules of genes: a multilayer approach
Characterizing the modular structure of cellular network is an important way to identify novel genes for targeted therapeutics. This is made possible by the rising of high-throughput technology. Unfortunately, computational methods to identify functional modules were limited by the data quality issues of high-throughput techniques. This study aims to integrate knowledge extracted from literature to further improve the accuracy of functional module identification. Our new model and algorithm were applied to both yeast and human interactomes. Predicted functional modules have covered over 90% of the proteins in both organisms, while maintaining a comparable overall accuracy. We found that the combination of both mRNA expression information and biomedical knowledge greatly improved the performance of functional module identification, which is better than those only using protein interaction network weighted with transcriptomic data, literature knowledge, or simply unweighted protein interaction network. Our new algorithm also achieved better performance when comparing with some other well-known methods, especially in terms of the positive predictive value (PPV), which indicated the confidence of novel discovery. Higher PPV with the multiplex approach suggested that information from both sources has been effectively integrated to reduce false positive. With protein coverage higher than 90%, our algorithm is able to generate more novel biological hypothesis with higher confidence.
- 2 May 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (1) , 225
Open AccessIntegrating data and knowledge to identify functional modules of genes: a multilayer approach
Characterizing the modular structure of cellular network is an important way to identify novel genes for targeted therapeutics. This is made possible by the rising of high-throughput technology. Unfortunately, computational methods to identify functional modules were limited by the data quality issues of high-throughput techniques. This study aims to integrate knowledge extracted from literature to further improve the accuracy of functional module identification. Our new model and algorithm were applied to both yeast and human interactomes. Predicted functional modules have covered over 90% of the proteins in both organisms, while maintaining a comparable overall accuracy. We found that the combination of both mRNA expression information and biomedical knowledge greatly improved the performance of functional module identification, which is better than those only using protein interaction network weighted with transcriptomic data, literature knowledge, or simply unweighted protein interaction network. Our new algorithm also achieved better performance when comparing with some other well-known methods, especially in terms of the positive predictive value (PPV), which indicated the confidence of novel discovery. Higher PPV with the multiplex approach suggested that information from both sources has been effectively integrated to reduce false positive. With protein coverage higher than 90%, our algorithm is able to generate more novel biological hypothesis with higher confidence.
- Open Access
- 19 February 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (1) , 1-12
Prediction of lncRNA-disease associations by integrating diverse heterogeneous information sources with RWR algorithm and positive pointwise mutual information
Long non-coding RNAs play an important role in human complex diseases. Identification of lncRNA-disease associations will gain insight into disease-related lncRNAs and benefit disease diagnoses and treatment. However, using experiments to explore the lncRNA-disease associations is expensive and time consuming. In this study, we developed a novel method to identify potential lncRNA-disease associations by Integrating Diverse Heterogeneous Information sources with positive pointwise Mutual Information and Random Walk with restart algorithm (namely IDHI-MIRW). IDHI-MIRW first constructs multiple lncRNA similarity networks and disease similarity networks from diverse lncRNA-related and disease-related datasets, then implements the random walk with restart algorithm on these similarity networks for extracting the topological similarities which are fused with positive pointwise mutual information to build a large-scale lncRNA-disease heterogeneous network. Finally, IDHI-MIRW implemented random walk with restart algorithm on the lncRNA-disease heterogeneous network to infer potential lncRNA-disease associations. Compared with other state-of-the-art methods, IDHI-MIRW achieves the best prediction performance. In case studies of breast cancer, stomach cancer, and colorectal cancer, 36/45 (80%) novel lncRNA-disease associations predicted by IDHI-MIRW are supported by recent literatures. Furthermore, we found lncRNA LINC01816 is associated with the survival of colorectal cancer patients. IDHI-MIRW is freely available at https://github.com/NWPU-903PR/IDHI-MIRW .
- 19 February 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (1) , 1-12
Open AccessPrediction of lncRNA-disease associations by integrating diverse heterogeneous information sources with RWR algorithm and positive pointwise mutual information
Long non-coding RNAs play an important role in human complex diseases. Identification of lncRNA-disease associations will gain insight into disease-related lncRNAs and benefit disease diagnoses and treatment. However, using experiments to explore the lncRNA-disease associations is expensive and time consuming. In this study, we developed a novel method to identify potential lncRNA-disease associations by Integrating Diverse Heterogeneous Information sources with positive pointwise Mutual Information and Random Walk with restart algorithm (namely IDHI-MIRW). IDHI-MIRW first constructs multiple lncRNA similarity networks and disease similarity networks from diverse lncRNA-related and disease-related datasets, then implements the random walk with restart algorithm on these similarity networks for extracting the topological similarities which are fused with positive pointwise mutual information to build a large-scale lncRNA-disease heterogeneous network. Finally, IDHI-MIRW implemented random walk with restart algorithm on the lncRNA-disease heterogeneous network to infer potential lncRNA-disease associations. Compared with other state-of-the-art methods, IDHI-MIRW achieves the best prediction performance. In case studies of breast cancer, stomach cancer, and colorectal cancer, 36/45 (80%) novel lncRNA-disease associations predicted by IDHI-MIRW are supported by recent literatures. Furthermore, we found lncRNA LINC01816 is associated with the survival of colorectal cancer patients. IDHI-MIRW is freely available at https://github.com/NWPU-903PR/IDHI-MIRW .
- 1 July 2018
- Published by Elsevier in Phytomedicine
- Vol. 46, 21-31
Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis
- 1 July 2018
- Published by Elsevier in Phytomedicine
- Vol. 46, 21-31
Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis